NOVARTIS AG (NVSEF)
Clinical trial NCT03876769 updates: 1. completion date: 2027-11-02 → 2027-10-19 2. primary completion date: 2027-11-02 → 2027-10-19
Clinical trial NCT03876769 updates: 1. completion date: 2027-11-02 → 2027-10-19 2. primary completion date: 2027-11-02 → 2027-10-19
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical